Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -2955.63% is 21% below its 5-year average of -2435.61%, near the high end of its 5-year range (-16415.33%–1021.21%).
43.57% above its 12-month average of -5237.64%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -4711.30%.
NET PROFIT MARGIN
-2955.63%
NET PROFIT MARGIN AVG TTM
-5237.64%
NET PROFIT MARGIN AVG 3Y
-3027.02%
NET PROFIT MARGIN AVG 5Y
-2435.61%
NET PROFIT MARGIN AVG 10Y
-1405.55%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+43.57%
CURRENT VS 3Y AVG
+2.36%
CURRENT VS 5Y AVG
-21.35%
CURRENT VS 10Y AVG
-110.28%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-1136680.77%
vs the sector median at left
Insight Molecular Diagnostics Inc.
Market Cap
$111.40M
Net Profit Margin
-2955.63%
TTM Avg
-5237.64%
3Y Avg
-3027.02%
5Y Avg
-2435.61%
Market Cap
$111.94M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$112.42M
Net Profit Margin
-175.78%
TTM Avg
-311.79%
3Y Avg
-369.50%
5Y Avg
-4193.27%
Market Cap
$112.67M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1605.97%
5Y Avg
-1070.65%
Market Cap
$109.91M
Net Profit Margin
-14.78%
TTM Avg
-35.00%
3Y Avg
-39.46%
5Y Avg
-38.67%
Market Cap
$109.38M
Net Profit Margin
-33.92%
TTM Avg
-11.74%
3Y Avg
-13.15%
5Y Avg
-11.88%
Market Cap
$114.08M
Net Profit Margin
-114.77%
TTM Avg
-120.72%
3Y Avg
-96.63%
5Y Avg
-81.33%
Market Cap
$114.25M
Net Profit Margin
-959.76%
TTM Avg
-1140.14%
3Y Avg
-4837.22%
5Y Avg
-4160.74%
Market Cap
$114.88M
Net Profit Margin
-1030.42%
TTM Avg
-1409.68%
3Y Avg
-958.30%
5Y Avg
-801.33%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | $111.40M | -2955.63% | -5237.64% | -3027.02% | -2435.61% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $112.42M | -175.78% | -311.79% | -369.50% | -4193.27% |
| Unicycive Therapeutics, Inc. (UNCY)vs › | $112.67M | 0.00% | 0.00% | -1605.97% | -1070.65% |
| Apyx Medical Corporation (APYX)vs › | $109.91M | -14.78% | -35.00% | -39.46% | -38.67% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $109.38M | -33.92% | -11.74% | -13.15% | -11.88% |
| MaxCyte, Inc. (MXCT)vs › | $114.08M | -114.77% | -120.72% | -96.63% | -81.33% |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.25M | -959.76% | -1140.14% | -4837.22% | -4160.74% |
| Caribou Biosciences, Inc. (CRBU)vs › | $114.88M | -1030.42% | -1409.68% | -958.30% | -801.33% |
| Genelux Corporation (GNLX)vs › | $114.34M | -422412.50% | -387587.50% | -197966.84% | -131977.89% |
Operating Margin
-754.1%
Net Profit Margin
-2955.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -4711.30% |
| 2026-03-31 | -13406.25% |
| 2025-12-31 | -2015.36% |
| 2025-09-30 | -4174.62% |
| 2025-06-30 | -1880.69% |
| 2025-03-31 | -312.02% |
| 2024-12-31 | -2255.11% |
| 2024-09-30 | -11733.04% |
| 2024-06-30 | -4355.77% |
| 2024-03-31 | -5186.93% |
| 2023-12-31 | -5092.99% |
| 2023-09-30 | -1512.59% |
| 2023-06-30 | -1799.78% |
| 2023-03-31 | 1021.21% |
| 2022-12-31 | -16415.33% |
| 2022-09-30 | -13929.85% |
| 2022-06-30 | -3502.11% |
| 2022-03-31 | -2708.16% |
| 2021-12-31 | -999.86% |
| 2021-09-30 | -1402.44% |
| 2021-06-30 | -516.90% |
| 2021-03-31 | -348.67% |
| 2020-12-31 | -1254.27% |
| 2020-09-30 | -1222.16% |
| 2020-06-30 | -6369.23% |
| 2020-03-31 | -48325.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
